Search Results - Wenstrup, R

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen.

    Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen. by Wenstrup, R J, Tsipouras, P, Byers, P H

    Published 1986
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta.

    Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta. by Wenstrup, R J, Willing, M C, Starman, B J, Byers, P H

    Published 1990
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Molecular analysis of the mitochondrial 12S rRNA and tRNA(Ser(UCN)) genes in paediatric subjects with non-syndromic hearing loss

    Molecular analysis of the mitochondrial 12S rRNA and tRNA(Ser(UCN)) genes in paediatric subjects with non-syndromic hearing loss by Li, R, Greinwald, J, Yang, L, Choo, D, Wenstrup, R, Guan, M

    Published 2004
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    A substitution at a non-glycine position in the triple-helical domain of pro alpha 2(I) collagen chains present in an individual with a variant of the Marfan syndrome.

    A substitution at a non-glycine position in the triple-helical domain of pro alpha 2(I) collagen chains present in an individual with a variant of the Marfan syndrome. by Phillips, C L, Shrago-Howe, A W, Pinnell, S R, Wenstrup, R J

    Published 1990
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS.

    COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. by Wenstrup, R J, Florer, J B, Willing, M C, Giunta, C, Steinmann, B, Young, F, Susic, M, Cole, W G

    Published 2000
    Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.

    Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. by Chipman, S D, Sweet, H O, McBride, D J, Davisson, M T, Marks, S C, Shuldiner, A R, Wenstrup, R J, Rowe, D W, Shapiro, J R

    Published 1993
    Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)

    Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S93... by Sharma, P, Barlow, W E, Godwin, A K, Pathak, H, Isakova, K, Williams, D, Timms, K M, Hartman, A R, Wenstrup, R J, Linden, H M, Tripathy, D, Hortobagyi, G N, Hayes, D F

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Development and Validation of Circulating Tumor Cell Enumeration (Epic Sciences) as a Prognostic Biomarker in Men with Metastatic Castration Resistant Prostate Cancer

    Development and Validation of Circulating Tumor Cell Enumeration (Epic Sciences) as a Prognostic Biomarker in Men with Metastatic Castration Resistant Prostate Cancer by Scher, H I, Armstrong, A J, Schonhoft, J D, Gill, A, Zhao, J L, Barnett, E, Carbone, E, Lu, J, Antonarakis, E S, Luo, J, Tagawa, S, dos Anjos, C H, Yang, Q, George, D, Szmulewitz, R, Danila, D C, Wenstrup, R, Gonen, M, Halabi, S

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset

    Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset by Chan, M K, Krebs, M-O, Cox, D, Guest, P C, Yolken, R H, Rahmoune, H, Rothermundt, M, Steiner, J, Leweke, F M, van Beveren, N J M, Niebuhr, D W, Weber, N S, Cowan, D N, Suarez-Pinilla, P, Crespo-Facorro, B, Mam-Lam-Fook, C, Bourgin, J, Wenstrup, R J, Kaldate, R R, Cooper, J D, Bahn, S

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: